Abstract
The aim of the study was to study the frequency and structure of concomitant diseases, comorbidity in 216 patients with the abdominaoncological diseases hospitalized for surgical treatment and their effect on the duration of inpatient treatment. It was found that 78,2% of patients with abdominal oncopathology had concomitant diseases, among which diseases of the cardiovascular system (76,8% of patients), type 2 diabetes mellitus (17,1%), chronic lung diseases (15,3%) and kidney diseases (11,6%) prevailed. The calculation of the Charlson comorbidity index revealed that 19.4% of patients had 1-2 points, 22,7% had 3-4 points, and 57,9% of patients had 5 or more points. The duration of treatment of patients in the intensive care unit, depending on the comorbidity index, did not have a statistically significant difference. The inpatient duration of treatment in patients with a Charlson comorbidity index above V points, compared with patients with an index of III-IV points, was significantly higher and amounted to: total – 16 [14-17] bed days (p=0.046), preoperative - 7 [6-8] (p=0,034) and postoperative 9 [8-10] bed days (p=0,042). The conducted study confirms the need for a targeted study of concomitant pathology in patients with abdominal oncological pathology, as a factor that significantly affects the tactics of surgical treatment and the timing of inpatient treatment.

This publication has 11 references indexed in Scilit: